dc.contributor.author | Biedenbach, Thomas | |
dc.contributor.author | Müller, Ralf | |
dc.date.accessioned | 2016-07-28T14:15:13Z | |
dc.date.accessioned | 2016-08-23T11:56:00Z | |
dc.date.available | 2016-07-28T14:15:13Z | |
dc.date.available | 2016-08-23T11:56:00Z | |
dc.date.issued | 2012 | |
dc.identifier.citation | International Journal of Project Management 2012, 30(5):621-635 | nb_NO |
dc.identifier.issn | 0263-7863 | |
dc.identifier.uri | http://hdl.handle.net/11250/2401079 | |
dc.description | This is the accepted, refereed and final manuscript to the article | nb_NO |
dc.description.abstract | This study explores how absorptive, innovative and adaptive capabilities within early project phases affect project and portfolio performance in pharmaceutical and biotechnology R&D organizations. A sequential qualitative – quantitative mixed method was used with 18 interviews and 80 responses to an online survey. The results show effects of absorptive, innovative and adaptive capabilities on short- and long-term project performance and portfolio performance. Absorptive and adaptive capabilities are the primary contributors to the performance outcome, whereas innovative capabilities are a minor contributor. Managerial and theoretical implications are discussed. | nb_NO |
dc.language.iso | eng | nb_NO |
dc.publisher | Elsevier | nb_NO |
dc.title | Absorptive, innovative and adaptive capabilities and their impact on project and project portfolio performance | nb_NO |
dc.type | Journal article | nb_NO |
dc.type | Peer reviewed | nb_NO |
dc.date.updated | 2016-07-28T14:15:13Z | |
dc.source.journal | International Journal of Project Management | nb_NO |
dc.identifier.doi | 10.1016/j.ijproman.2012.01.016 | |
dc.identifier.cristin | 924013 | |
dc.description.localcode | 1, Forfatterversjon | nb_NO |